The provisional changed the math

An established US R&D organization had built its patent portfolio for years with a specialty IP boutique. They tested Tradespace Counsel on a single pharmaceutical formulation provisional. The result reset their thinking on what drafting and filing should cost, take, and feel like.

Customer

A US-based research and development organization

Engagement

One US Provisional Patent Application — pharmaceutical formulation

Outcome

Full consolidation of drafting and filing to Tradespace Counsel

A test case, not a trust fall.

The IP team came to Tradespace with a specific filing in mind: a novel pharmaceutical formulation requiring nuanced functional claim language against a tight prior-art delta. It was the kind of invention they would normally route to their specialty IP boutique without a second thought.

Instead, they ran it as a provisional through Tradespace Counsel. The premise was modest — a single low-stakes filing, on the assumption that a managed service might be good enough for early-stage protection while the more strategic utility work continued at the boutique.

Five days later, they had a filed application. And a different question on the table.

The provisional was filed at a fraction of the team’s typical outside-counsel cost. But what shifted the conversation internally wasn’t the savings or the speed. It was the quality of the engagement — and specifically, who showed up to do the work.

A note on cadence

Most provisional engagements at the customer’s incumbent boutique ran six weeks from disclosure to filed. The Tradespace timeline of five days was not a stripped-down version of the same process. It was the same process, run with AI-assisted drafting in parallel with attorney review.

The provisional that changed their minds.

The first signal came from the inventor.

The matched attorney opened the engagement with a structured technical interview that registered, immediately, as substantive. The technology was non-trivial — a specialized pharmaceutical formulation where claim scope hinges on tightly defined functional parameters and a narrow novelty delta. The kind of invention where the difference between filable and unfilable is paragraphs of careful structural fallback in the specification.

The inventor was a senior PhD-credentialed scientist with deep domain expertise in the precise field of the invention. She had specific expectations about what understanding the technology looked like in practice. The attorney met them on the first call.

Then the executive review brief landed.

Not a draft of the application — a separate, structured document the matched attorney produced alongside the draft. It opened with the strategic context, walked through the three independent claims (composition, method of treating, method of preparation), and articulated the novelty delta with precision. What would have taken the inventor days of solitary review collapsed into a half-hour read.

And then there was the section that, more than anything else, dissolved the team’s quiet skepticism about an AI-assisted model.

A subsection labeled AI / Drafter Artifacts to Check. The attorney explicitly flagged where the AI-assisted draft might have over-fit to the inventor’s specific experimental data — surfacing a §112 enablement risk on functional claim language, and warning that mathematical equations pasted from the underlying research could improperly narrow claim scope. In writing, on the page, an experienced pharmaceutical patent attorney was visibly correcting AI work and showing the team where his judgment had overridden the model’s output.

Any concern that AI would lower the quality bar evaporated when it became clear that the AI was the productivity layer, and the attorney was the accountability layer.

The brief did one more thing the team hadn’t expected: it gave the inventor confidence to sign off on the application without a second round of attorney back-and-forth. The strategic frame, the §101 risk note, the §112 fallbacks, the prior-art delta — all of it was already on the page in the form the inventor needed.

The decision to consolidate.

After the provisional, the internal conversation shifted from is this good enough for early-stage filings to why are we routing utilities through anyone else.

The team consolidated all drafting and filing work to Tradespace Counsel.

Their existing outside counsel didn’t go anywhere. The relationship continues — but for licensing, contested-prosecution strategy, and litigation, where their senior partner’s experience is the highest and best use of every dollar the team spends. They didn’t replace their firm. They re-allocated.

The numbers, after consolidation, look like this: